Results 151 to 160 of about 22,830 (226)

ROS1 wt Allele [PDF]

, 2020
openaire   +1 more source

Case Report: Dynamic TKI combination strategies for EGFR-mutant NSCLC with acquired ROS1 fusion and brain metastases. [PDF]

Front Oncol
Yang H, Da Y, Shen G, Sun QY, Yao ZY, Zhou YJ.   +5 more
europepmc   +1 more source

<i>EZR-ROS1</i>-rearranged lung adenocarcinoma presenting as diffuse cystic lung disease mimicking lymphangioleiomyomatosis: a case report. [PDF]

Transl Lung Cancer Res
You Z, Bi W, Cao H, Wang Y, Shi C, Zhou Y, Li L.   +6 more
europepmc   +1 more source

Acquired <i>ROS1</i> Intragenic Rearrangements as a Resistance Mechanism in <i>EGFR</i>-Mutant Non-Small Cell Lung Cancer: A Case Series. [PDF]

Curr Oncol
Liu PT, Chen YL, Chen WL, Ho CL, Lee CH.
europepmc   +1 more source

ROS1 Gene Mutation [PDF]

, 2020
openaire   +1 more source

Response to crizotinib treatment for ROS1 p.H1999N mutation and secondary EGFR p.V774M mutation after drug resistance: a Case Report. [PDF]

Front Pharmacol
He Y, Tang Y, Yu R, Liu Y.
europepmc   +1 more source

ROS1 Gene Rearrangement [PDF]

, 2020
openaire   +1 more source

Exploring the Impact of Multiple Gene Mutations on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Response in Asian Nonsmall Cell Lung Cancer Patients. [PDF]

ACS Pharmacol Transl Sci
Jing R, Miao Y, Daut UN, How SH, Zhang F, Stanslas J.   +5 more
europepmc   +1 more source

ROS1 Rearrangement Analysis [PDF]

, 2020
openaire   +1 more source

Severe Immune-Related Adverse Events Associated with Durable Antitumor Responses Following Immune Checkpoint Inhibitor Therapy: Two Case Reports. [PDF]

Cancer Manag Res
Chen Q, Lin X, Chen L, Yao J, Yan Y, Zhang X, Yang D, Lin X, Chen S, Chen X, Yu N.   +10 more
europepmc   +1 more source